Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
dc.contributor.author | Sharma, A C | en_US |
dc.contributor.author | Thorat, S N | en_US |
dc.contributor.author | Nayar, U | en_US |
dc.contributor.author | Kulkarni, S K | en_US |
dc.date.accessioned | 1991-04-01 | en_US |
dc.date.accessioned | 2009-06-01T05:47:53Z | |
dc.date.available | 1991-04-01 | en_US |
dc.date.available | 2009-06-01T05:47:53Z | |
dc.date.issued | 1991-04-01 | en_US |
dc.description.abstract | Electroencephalographic (EEG) activity in neocortex of rats following intracerebroventricular (icv) administration of NMDA (0.25-2 nmol/10 microliters) and its modification by noncompetitive NMDA-receptor antagonists, dizocilpine (MK-801) (0.025-0.1 mg/kg, ip) and ketamine (10-50 mg/kg, ip) was recorded at 0, 0.5, 4, 8 and 24 hr with chronically implanted electrodes. NMDA (0.25 and 1 nmol) showed longer lasting decrease in frequency in cortical neurons while 2 nmol produced convulsions and death. Administration of MK 801 (0.05 mg/kg) and ketamine (50 mg/kg) prior to NMDA offered protection in 40% of animals against NMDA-induced convulsions and blocked NMDA-induced long term influence. However, ketamine and MK 801 showed an increase in percent amplitude and also had long lasting effects per se. In conscious mice, NMDA (0.5-10 nmol/microliters icv) induced dose dependent convulsions. Both MK 801 and ketamine showed potent anticonvulsant effect. Ethanol (0.5-2 g/kg, ip) also offered significant protection against NMDA-induced convulsions. MK 801 (0.1 mg/kg) when administered concurrently with ethanol (0.5 g/kg) exhibited synergistic anticonvulsant effect. The EEG study in rats and effect of NMDA in conscious mice provide a direct evidence for the role of NMDA-receptor system in convulsions and in anticonvulsant action of ethanol. | en_US |
dc.description.affiliation | Department of Pharmaceutical Sciences, Panjab University, Chandigarh. | en_US |
dc.identifier.citation | Sharma AC, Thorat SN, Nayar U, Kulkarni SK. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice. Indian Journal of Physiology and Pharmacology. 1991 Apr; 35(2): 111-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/106890 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.ijpp.com | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Cerebral Cortex --drug effects | en_US |
dc.subject.mesh | Dizocilpine Maleate --pharmacology | en_US |
dc.subject.mesh | Electroencephalography --drug effects | en_US |
dc.subject.mesh | Ethanol --pharmacology | en_US |
dc.subject.mesh | Ketamine --pharmacology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | N-Methylaspartate --antagonists & inhibitors | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Receptors, N-Methyl-D-Aspartate --metabolism | en_US |
dc.subject.mesh | Seizures --chemically induced | en_US |
dc.title | Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1